Prognostic significance of stathmin expression in correlation with metastasis and clinicopathological characteristics in human ovarian carcinoma

Acta Histochemica

Volumn 110, Issue 1, 2008, Pages 59-65

  Wei, San Hua ^a   Lin, Fang ^a   Wang, Xi ^a   Gao, Ping ^a   Zhang, Hui Zhong ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Biopsies; Ovarian carcinoma; Paraffin wax embedded tissue; Prognostic factor; Stathmin

Indexed keywords

BETA ACTIN; BIOLOGICAL MARKER; MESSENGER RNA; STATHMIN;

ADULT; ANALYTICAL PARAMETERS; ARTICLE; CANCER PATIENT; CANCER TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; METASTASIS; OVARY CARCINOMA; PROGNOSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SAMPLE; TUMOR BIOPSY;

EID: 37549043960     PISSN: 00651281     EISSN: 16180372     Source Type: Journal    
DOI: 10.1016/j.acthis.2007.06.002     Document Type: Article

References (27)

1. Balachandran R., Welsh M.J., and Day B.W. Altered levels and regulation of stathmin in paclitaxel-resistant ovarian cancer cells. Oncogene 22 (2003) 8924-8930
2. Bieche I., Lachkar S., Becette V., et al. Overexpression of the stathmin gene in a subset of human breast cancer. Br J Cancer 78 (1998) 701-709
3. Bondy S., Elit L., Chen Z., Law C., and Paszat L. Prognostic factors for women with stage 1 ovarian cancer with or without adhesions. Eur J Gynaecol Oncol 27 (2006) 585-588
4. Brattsand G. Correlation of oncoprotein 18/stathmin expression in human breast cancer with established prognostic factors. Br J Cancer 83 (2000) 311-318
5. Clement K.D., and Connor P.D. Tumors of the female reproductive organs. In: Taylor R.B. (Ed). Family medicine: principles and practice. 5th ed (1998), Springer, New York 916-924
6. DiSilvestro P., Peipert J.F., Hogan J.W., and Granai C.O. Prognostic value of clinical variables in ovarian cancer. J Clin Epidemiol 50 (1997) 501-505
7. Finke J., Fritzen R., Ternes P., Lange W., and Dolken G. An improved strategy and a useful housekeeping gene for RNA analysis from formalin-fixed, paraffin-embedded tissues by PCR. Biotechniques 14 (1993) 448-453
8. Friedrich B., Gronberg H., Landstrom M., Gullberg M., and Bergh A. Differentiation-stage specific expression of oncoprotein 18 in human and rat prostatic adenocarcinoma. Prostate 27 (1995) 102-109
9. Hanash S.M., Strahler J.R., Kuick R., Chu E.H.Y., and Nichols D. Identification of a polypeptide associated with the malignant phenotype in acute leukemia. J Biol Chem 263 (1988) 12813-12815
10. Hisaoka M., Tsuji S., Morimitsu Y., et al. Detection of TLS/FUSCHOP fusion transcripts in myxoid and round cell liposarcomas by nested reverse transcription-polymerase chain reaction using archival paraffin-embedded tissues. Diagn Mol Pathol 7 (1998) 96-101
11. Hoskins W.J. Epithelial ovarian cancer: principles of primary surgery. Gynecol Oncol 55 (1994) S91-S96
12. Luo X.N., Mookerjee B., Ferrari A., Mistry S., and Atweh G.F. Regulation of phosphoprotein p18 in leukemic cells. Cell cycle regulated phosphorylation by p34cdc2 kinase. J Biol Chem 269 (1994) 10312-10318
13. Marklund U., Osterman O., Melander H., Bergh A., and Gullberg M. The phenotype of a "Cdc2 kinase target site-deficient" mutant of oncoprotein 18 reveals a role of this protein in cell cycle control. J Biol Chem 269 (1994) 30626-30635
14. Marklund U., Larsson N., Gradin H.M., Brattsand G., and Gullberg M. Oncoprotein 18 is a phosphorylation-responsive regulator of microtubule dynamics. EMBO J 15 (1996) 5290-5298
15. Ochiai K. [Prognostic factors of ovarian cancer] Gan To Kagaku Ryoho. Review 33 (2006) 2014-2019 [Japanese]
16. Ortega N., Navarro J.A., Nicolás L., et al. Evaluation of Chlamydophila abortus DNA extraction protocols for polymerase chain reaction diagnosis in paraffin-embedded tissues. J Vet Diagn Invest 19 (2007) 421-425
17. Osaka E., Suzuki T., Osaka S., et al. Survivin as a prognostic factor for osteosarcoma patients. Acta Histochem Cytochem 39 (2006) 95-100
18. Ovarian Cancer. ACOG Educational Bulletin Number 250, August 1998. In: 1999 Compendium of Selected Publications. Washington, DC: The American College of Obstetricians and Gynecologists; 1999. p. 665-73.
19. Pectasides D, Fountzilas G, Aravantinos G, Bamias A, Kalofonos HP, Skarlos D, et al. Epithelial ovarian carcinoma in younger vs older women: is age an independent prognostic factor? The Hellenic Oncology Cooperative Group experience. Int J Gynecol Cancer 2007 Mar 15 [Epub ahead of print].
20. Price D.K., Ball J.R., Bahrani-Mostafavi Z., Vachris J.C., Kaufman J.S., Naumann R.W., et al. The phosphoprotein Op18/stathmin is differentially expressed in ovarian cancer. Cancer Invest 18 (2000) 722-730
21. Rades D., Schild S.E., and Dunst J. Radiotherapy is effective for metastatic spinal cord compression in patients with epithelial ovarian cancer. Int J Gynecol Cancer 17 (2007) 263-265
22. Rubin C.I., and Atweh G.F. The role of stathmin in the regulation of the cell cycle. J Cell Biochem 93 (2004) 242-250
23. Satthapong D., Tangjitgamol S., Manusirivithaya S., and Pataradool K. Chemotherapy in patients with recurrent or refractory epithelial ovarian cancer. J Med Assoc Thai 90 (2007) 411-419
24. Stanta G., and Schneider C. RNA extracted from paraffin-embedded human tissues is amenable to analysis by PCR amplification. Biotechniques 11 (1991) 304 306, 308
25. Walter-Yohrling J., Cao X., Callahan M., Weber W., Morgenbesser S., Madden S.L., et al. Identification of genes expressed in malignant cells that promote invasion. Cancer Res 63 (2003) 8939-8947
26. Woenckhaus J., Steger K., Sturm K., Munstedt K., Franke F.E., and Fenic I. Prognostic value of PIK3CA and phosphorylated AKT expression in ovarian cancer. Virchows Arch 450 (2007) 387-395 Epub 2007 Feb 15
27. Young R.C. Gynecologic malignancies. In: Fauci A.S., Braunwald E., Isselbacher K.J., Wilson J.D., Martin J.B., and Kasper D.L. (Eds). Harrison's principles of internal medicine. 14th ed (1998), McGraw-Hill, New York 605-611